Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 1.15
- Piotroski Score 4.00
- Grade Market Perform
- Symbol (EHAB)
- Company Enhabit, Inc.
- Price $7.47
- Changes Percentage (0.13%)
- Change $0.01
- Day Low $7.26
- Day High $7.48
- Year High $11.74
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company also offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. As of March 31, 2022, it operated in 252 home health agencies and 99 hospice agencies across 34 states. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was incorporated in 2014 and is headquartered in Dallas, Texas. As of July 1, 2022, Enhabit, Inc. operates as a standalone company.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/12/2025
- Fiscal Year End N/A
- Average Stock Price Target $10.25
- High Stock Price Target $12.00
- Low Stock Price Target $8.50
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.65
- Trailing P/E Ratio -5.57
- Forward P/E Ratio -5.57
- P/E Growth -5.57
- Net Income $-80,500,000
Income Statement
Quarterly
Annual
Latest News of EHAB
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Trespassing motorcycles "ruined" wilderness rehabilitation project in Oakdale, police say
Motorcycle riders in Oakdale ruined a recent ecological rehabilitation project at the Stanley F. Wakefield Wilderness Area, prompting potential vandalism charges. The city is located in Stanislaus Cou...
By CBS News | 1 week ago -
Inside America's controversial 'tough love' teen drug rehab
Allegations of torture and brainwashing in the Straight Inc programme are revealed by those who claim they were forced into it. Meanwhile, popular comedian Frank Skinner finds success in podcasting af...
By The Guardian | 2 weeks ago -
Inside Tyrone Mings' 445-day road to recovery: Severe ACL injury, global rehab and muscle atrophy
Tyrone Mings faced his second significant knee injury, disrupting his career. His recovery involved setbacks, mental strain, and extensive rehab. Mings' determination and support systems aided his ret...
By The New York Times | 3 weeks ago
